826. HIV Treatment: New Regimens, New Strategies
Session: Symposium: State-of-the-Art in HIV
Saturday, October 22, 2011: 9:15 AM
Room: 210ABC

Paul Sax, MD, FIDSA, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Paul Sax, MD
Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases and the HIV Program at Brigham and Women's Hospital (BWH), Boston. He has been on the faculty at Harvard Medical School since 1992, where he is currently an Associate Professor of Medicine. Dr. Sax received his MD from Harvard Medical School in 1987. He served his residency in Internal Medicine at BWH, while continuing his postdoctoral education with a fellowship in the Infectious Disease Unit of Massachusetts General Hospital. Dr. Sax is board certified in Internal Medicine and Infectious Diseases. He is Editor-in-Chief of AIDS Clinical Care, is on the Peer Review board of the HIV/AIDS Section of UpToDate, and the editorial board of Medscape HIV/AIDS. Dr. Sax is also on the core faculty of the International AIDS Society - USA and the New England AIDS Education and Training Center.
In addition to his clinical and teaching work, Dr. Sax is actively involved in HIV research. Ongoing areas of research interest include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group.

See more of: State-of-the-Art in HIV
See more of: Symposium
<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.